Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.535
+0.025 (1.66%)
At close: Aug 14, 2026, 4:00 PM EDT
1.610
+0.075 (4.89%)
After-hours: Aug 14, 2026, 7:53 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $5.65 million as of August 14, 2026. Its market cap has increased by 106.00% in one year.
Market Cap
5.65M
Enterprise Value
742.92K
1-Year Change
106.00%
Ranking
Category
Stock Price
$1.54
ChartMarket Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $5.65M, a decrease of -100.00%. That is a compound annual growth rate of -83.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 5.65M | 52.14% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curanex Pharmaceuticals | 6.22M |
| Cardio Diagnostics Holdings | 6.04M |
| Acurx Pharmaceuticals | 6.00M |
| Addex Therapeutics | 5.93M |
| PharmaCyte Biotech | 5.92M |
| Ensysce Biosciences | 5.88M |
| Dermata Therapeutics | 5.87M |
| BioRestorative Therapies | 5.76M |